FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013079805> ?p ?o ?g. }

• W2013079805 abstract "Several months have passed since news broke of a horrific compounding tragedy at the New England Compounding Center (NECC) in Framingham, Massachusetts. An outbreak of fungal meningitis in fall 2012 was traced to contaminated methylprednisolone acetate prepared by the NECC. According to the US Centers for Disease Control and Prevention (CDC), as of May 11, 2013, 55 deaths and a total case count of 741 had been attributed to the contamination, and the numbers continue to rise. Patients who received medications from this pharmacy have also experienced paraspinal, spinal, and peripheral joint infections. The Institute for Safe Medication Practices (ISMP) has compiled a list of selected compounding misadventures since the 1990s. For legal reasons, many compounding misadventures never become public, but the US Food and Drug Administration (FDA) has been actively inspecting compounding pharmacies with a history or suspicion of large-scale compounding or quality concerns. Compounding problems are not isolated to the United States. Recently, more than 1200 cancer patients in Ontario and New Brunswick received chemotherapy solutions with concentrations below labelled specifications. It appears that jurisdictional issues regarding proper oversight of this operation and others were similar to the problems identified in relation to the NECC event. It is time to face our naivete and our occasional arrogance about safe compounding practices. We must learn from these events and take measures to ensure that we are doing everything possible to protect patients and reduce the risk of improperly compounded sterile preparations. On a personal level, I have been profoundly affected by the NECC event, and I continue to be perplexed by the actions of some of my colleagues who somehow still believe that the principles of contamination control and robust quality systems don’t apply to them. As a pharmacist and a potential future patient, I ask, “What are you doing for your present-day and future patients in light of these recent issues?” Whether you agree or disagree with United States Pharmacopeia (USP) Chapter and other USP chapters critical to compounding or the Pharmaceutical Inspection Cooperation Scheme’s compounding guide, the message couldn’t be clearer. Business as usual is no longer acceptable. We must embrace standards and guidelines that incorporate evidencebased science and best practices that have been vetted through public comment and review cycles. More specifically, it is time to perform risk assessments of the compounding methods used in our own pharmacies, so that inherent risks can be identified and mitigated through detailed policies and procedures, robust training programs and quality systems. Pharmacy staff members must know not only what is expected of them as they prepare sterile dosage forms, but also why they are expected to do these things. We must move away from the pure apprenticeship model of training and instead deploy methods and procedures that establish a solid foundation for quality work practices that will prevent compounding errors. Pharmacy practitioners are increasingly challenged to prepare compounded sterile dosage forms that are not commercially available, at times using nonsterile active pharmaceutical ingredients. Handling and transforming these components into appropriate sterile dosage forms may require greater experience and expertise than a particular pharmacy possesses. In such cases, we must take these limitations into account and recognize the risks they pose to our patients. In particular, only robust and validated procedures should be used. We have the responsibility to ensure that any compounded preparation is what it is expected to be and, to the degree possible, to ensure and measure its sterility. Conversely, if we don’t have the requisite expertise, we should not undertake these activities. Historically, pharmacists compounded medications in a “just in time” manner. However, current distribution models require that more compounded sterile preparations be stored at room temperature, prompting the desire for longer beyond-use dating. The sterility tests described in USP Chapter" @default.
• W2013079805 created "2016-06-24" @default.
• W2013079805 creator A5083985898 @default.
• W2013079805 date "2013-06-28" @default.
• W2013079805 modified "2023-09-25" @default.
• W2013079805 title "Lessons Learned from Compounding Tragedies" @default.
• W2013079805 doi "https://doi.org/10.4212/cjhp.v66i3.1250" @default.
• W2013079805 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3694934" @default.
• W2013079805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23814281" @default.
• W2013079805 hasPublicationYear "2013" @default.
• W2013079805 type Work @default.
• W2013079805 sameAs 2013079805 @default.
• W2013079805 citedByCount "2" @default.
• W2013079805 countsByYear W20130798052014 @default.
• W2013079805 countsByYear W20130798052020 @default.
• W2013079805 crossrefType "journal-article" @default.
• W2013079805 hasAuthorship W2013079805A5083985898 @default.
• W2013079805 hasBestOaLocation W20130798051 @default.
• W2013079805 hasConcept C104863432 @default.
• W2013079805 hasConcept C207673951 @default.
• W2013079805 hasConcept C512399662 @default.
• W2013079805 hasConcept C71924100 @default.
• W2013079805 hasConcept C98274493 @default.
• W2013079805 hasConceptScore W2013079805C104863432 @default.
• W2013079805 hasConceptScore W2013079805C207673951 @default.
• W2013079805 hasConceptScore W2013079805C512399662 @default.
• W2013079805 hasConceptScore W2013079805C71924100 @default.
• W2013079805 hasConceptScore W2013079805C98274493 @default.
• W2013079805 hasLocation W20130798051 @default.
• W2013079805 hasLocation W20130798052 @default.
• W2013079805 hasLocation W20130798053 @default.
• W2013079805 hasLocation W20130798054 @default.
• W2013079805 hasOpenAccess W2013079805 @default.
• W2013079805 hasPrimaryLocation W20130798051 @default.
• W2013079805 hasRelatedWork W115317398 @default.
• W2013079805 hasRelatedWork W1441297434 @default.
• W2013079805 hasRelatedWork W1777279497 @default.
• W2013079805 hasRelatedWork W1967302237 @default.
• W2013079805 hasRelatedWork W1972278970 @default.
• W2013079805 hasRelatedWork W2004328234 @default.
• W2013079805 hasRelatedWork W2008856729 @default.
• W2013079805 hasRelatedWork W2025667297 @default.
• W2013079805 hasRelatedWork W2044099783 @default.
• W2013079805 hasRelatedWork W2050196707 @default.
• W2013079805 hasRelatedWork W2073967349 @default.
• W2013079805 hasRelatedWork W2117240761 @default.
• W2013079805 hasRelatedWork W2143558777 @default.
• W2013079805 hasRelatedWork W2276547047 @default.
• W2013079805 hasRelatedWork W2323945652 @default.
• W2013079805 hasRelatedWork W2611396836 @default.
• W2013079805 hasRelatedWork W2790388682 @default.
• W2013079805 hasRelatedWork W3157128253 @default.
• W2013079805 hasRelatedWork W56897900 @default.
• W2013079805 hasRelatedWork W2003755023 @default.
• W2013079805 isParatext "false" @default.
• W2013079805 isRetracted "false" @default.
• W2013079805 magId "2013079805" @default.
• W2013079805 workType "article" @default.